Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigens
Min Yao, … , David Tuveson, Douglas T. Fearon
Min Yao, … , David Tuveson, Douglas T. Fearon
Published September 26, 2023
Citation Information: JCI Insight. 2023;8(21):e172449. https://doi.org/10.1172/jci.insight.172449.
View: Text | PDF
Research Article Immunology Oncology

Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigens

  • Text
  • PDF
Abstract

Intratumoral B cell responses are associated with more favorable clinical outcomes in human pancreatic ductal adenocarcinoma (PDAC). However, the antigens driving these B cell responses are largely unknown. We sought to discover these antigens by using single-cell RNA sequencing (scRNA-Seq) and immunoglobulin (Ig) sequencing of tumor-infiltrating immune cells from 7 primary PDAC samples. We identified activated T and B cell responses and evidence of germinal center reactions. Ig sequencing identified plasma cell (PC) clones expressing isotype-switched and hypermutated Igs, suggesting the occurrence of T cell–dependent B cell responses. We assessed the reactivity of 41 recombinant antibodies that represented the products of 235 PCs and 12 B cells toward multiple cell lines and PDAC tissues and observed frequent staining of intracellular self-antigens. Three of these antigens were identified: the filamentous actin (F-actin), the nucleic protein RuvB like AAA ATPase 2 (RUVBL2), and the mitochondrial protein heat shock protein family D (Hsp60) member 1 (HSPD1). Antibody titers against F-actin and HSPD1 were substantially elevated in the plasma of patients with PDAC compared with healthy donors. Thus, PCs in PDAC produce autoantibodies reacting with intracellular self-antigens, which may result from promotion of preexisting, autoreactive B cell responses. These observations indicate the chronic inflammatory microenvironment of PDAC can support the adaptive immune response.

Authors

Min Yao, Jonathan Preall, Johannes T.-H. Yeh, Darryl Pappin, Paolo Cifani, Yixin Zhao, Sophia Shen, Philip Moresco, Brian He, Hardik Patel, Amber N. Habowski, Daniel A. King, Kara Raphael, Arvind Rishi, Divyesh Sejpal, Matthew J. Weiss, David Tuveson, Douglas T. Fearon

×

Figure 6

Identification of F-actin as antigen in PDAC.

Options: View larger image (or click on image) Download as PowerPoint
Identification of F-actin as antigen in PDAC.
(A) Proteins that were imm...
(A) Proteins that were immunoprecipitated by antibody 8-3 from lysates of MiaPaca2 cells were separated by SDS-PAGE and visualized by silver staining. Two bands were identified by mass spectrometry (red arrowheads). (B) MiaPaca2 cells were costained with 8-3, phalloidin, and an antibody specific for MYH10 after 30-minute treatment of the cells with DMSO or cytochalasin D. (C) Dot blot assay is shown of the reaction with F-actin or G-actin of 8-3, isotype control IgG, and a commercial Actin-specific antibody (Actin Ab). (D) The binding of incremental concentrations of 8-3 to F-actin was measured by ELISA. Each experiment was repeated at least twice. Scale bars in B are 50 μm.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts